SEC Form 4 · accession 0001171843-16-008734
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
W Thorpe McKenzie
Director · 10% Owner
Period of report
Mar 17, 2016
Accepted (ET)
Mar 22, 2016 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Mar 17, 2016 | O | 500,000 | $10.00 | A | 3,898,600 | D | |
| Common Shares | holding | — | — | — | 5,000 | I | By Trust | |
| Common Shares | holding | — | — | — | 5,000 | I | By Trust | |
| Common Shares | holding | — | — | — | 100,000 | I | By Foundation | |
| Common Shares | holding | — | — | — | 100,000 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $10.00 | Mar 17, 2016 | O | 500,000 | D | Mar 20, 2014 | Mar 20, 2016 | Common Stock | 500,000 | 0 | D |
Explanation of responses
- F1On March 17, 2016, the Reporting Person exercised his option to acquire 500,000 shares of the Issuer's common stock from the CEO of the Issuer at an exercise price of $10.00 per share.
- F2The Reporting Person purchased an option from the CEO of the Issuer on March 20, 2014 which granted him an option to acquire 500,000 shares of the Issuer's common stock at an exercise price of $10.00 per share for a period of two years from the grant date.